Celgene to collaborate with PTC on advancing medication discovery efforts PTC Therapeutics.

Celgene to collaborate with PTC on advancing medication discovery efforts PTC Therapeutics, Inc. today announced that Celgene Corporation has exercised its substitute for collaborate on advancing medication discovery attempts on an oncology focus on addressed through the application of PTC’s GEMS technology buy viagra . Related StoriesSTA inks permit and commercialisation agreement with PharmaMar for APLIDIN AMSBIO launches Mimetix 3D cell tradition scaffolds for drug discovery, oncology researchFDA approves LONSURF for treatment of sufferers with metastatic colorectal cancerIn September 2007, Celgene made a $20 million equity expense in PTC, which included an option for an exclusive research agreement.